Dr. Alborz Mahdavi, CEO of Protomer Technologies Inc. to present at the Biotech Showcase™ Annual Conference on January 8, 2018
Pasadena, CA – Protomer Technologies Inc., today announced that it will present at Biotech Showcase ™ 2018, to be held January 8–10 during the most important week in healthcare at the Hilton San Francisco Union Square.
Dr. Alborz Mahdavi, CEO of Protomer will present at the Biotech Showcase™ as follows:
January 8, 2018
Time: 4:45 pm (PST)
Room: Franciscan – D (Ballroom Level)
Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San Francisco, CA (United States)
Protomer Technologies is a pre-clinical stage biotechnology company based in Pasadena, California. Protomer’s pipeline of pre-clinical assets includes a number of novel insulins that Dr. Mahdavi will discuss at Biotech Showcase.
Biotech Showcase™, produced by Demy-Colton and EBD Group, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference.
Sara Demy-Colton, CEO of Demy-Colton, said: “We are delighted that Dr. Alborz Mahdavi will be presenting at Biotech Showcase this year. Biotech Showcase is the perfect platform for life science companies to showcase their innovation and seek out their next deal. This year again we are thrilled to be hosting what we believe will be the great business development opportunity of 2018.”
Additional links and information:
contact@protomer.com
www.protomer.com
Follow Biotech Showcase on Twitter: @EBDGroup and @Demy_Colton – #BiotechShowcase